Histone H4-related osteogenic growth peptide (OGP): a novel circulating stimulator of osteoblastic activity.
Animal research · 1992
- What was studied
- Osteoblast cultures and rats
- Main finding
- Synthetic 14-amino-acid OGP increased osteoblast proliferation and alkaline-phosphatase activity in culture and increased bone mass in injected rats.
Study data at a glance
- Participants or experimental model
- Osteoblast cultures and rats
- Reported results
- Synthetic 14-amino-acid OGP increased osteoblast proliferation and alkaline-phosphatase activity in culture and increased bone mass in injected rats.
Study limitations and source details
Study limitations
- Preclinical endpoints do not establish fracture prevention or benefit in people.
- The full-length peptide must be distinguished from its 10–14 fragment and tissue mixtures.
Source details
Journal article
Original publication metadata and indexed abstract checked; full methods and tables not appraised.
Indexed abstract reviewed
Sources checked
Citation
I. Bab, D. Gazit, M. Chorev, A. Muhlrad, A. Shteyer, Z. Greenberg, M. Namdar, A. Kahn. Histone H4-related osteogenic growth peptide (OGP): a novel circulating stimulator of osteoblastic activity. EMBO Journal. 11(5):1867–1873
Study source ↗ · DOI 10.1002/j.1460-2075.1992.tb05238.x · Bibliography entry · Link to this summary